$344.7 M

KRYS Mkt cap, 04-Dec-2018
Krystal Biotech Net income (FY, 2016)-1.1 M
Krystal Biotech EBIT (FY, 2016)-1.1 M
Krystal Biotech Cash, 31-Dec-20161.9 M

Krystal Biotech Income Statement

Annual

USDFY, 2016

R&D expense

741.0k

General and administrative expense

402.0k

Operating expense total

1.1m

EBIT

(1.1m)

Interest expense

7.0k

Net Income

(1.1m)

Krystal Biotech Balance Sheet

Annual

USDFY, 2016

Cash

1.9m

Prepaid Expenses

246.0k

Current Assets

2.2m

PP&E

13.0k

Total Assets

2.2m

Accounts Payable

42.0k

Current Liabilities

43.0k

Total Liabilities

1.9m

Additional Paid-in Capital

33.0k

Retained Earnings

(1.1m)

Total Equity

289.0k

Financial Leverage

7.6 x

Krystal Biotech Cash Flow

Annual

USDFY, 2016

Net Income

(1.1m)

Depreciation and Amortization

2.0k

Cash From Operating Activities

(1.3m)

Purchases of PP&E

(15.0k)

Cash From Investing Activities

(15.0k)

Cash From Financing Activities

3.2m

Net Change in Cash

1.9m

Krystal Biotech Ratios

USDY, 2016

Financial Leverage

7.6 x
Report incorrect company information

Krystal Biotech Employee Rating

00 votes
Culture & Values
N/A
Work/Life Balance
N/A
Senior Management
N/A
Salary & Benefits
N/A
Career Opportunities
N/A
Source